NEWS, EVENTS, and DEADLINES

January 22, 2025

Upcoming NJ ACTS, Rutgers, Princeton and NJIT Events

NJ ACTS Genetically informed Research, Education, And Treatment (GREAT) Core

Listening Sessions

The GREAT Core supports translational science research capacity through consultation and training on genetically informed research designs and engages the broader community in understanding the role of genetics in health.

Want to learn more about polygenic scoring, or how to navigate publicly available genetic data?

We want to hear from you to best serve our community!

If you cannot make a listening session - request an individual 30-minute consultation.

NJ ACTS GREAT Core

Guest Seminar

Disentangling the genetics of comorbid substance use and depression

If you would like to schedule a 1-1 meeting during Dr. Hartwell's campus visit, please contact host Dr. Jessica Salvatore at jessica.salvatore@rutgers.edu.

This event is co-sponsored by the Genes, Neurodevelopment, and Addictions Program in the Center for Psychiatric Health and Genomics and the NJACTS Genetically informed Research, Education, and Treatment Core.

Learn about the impact your research or innovation could have in solving real-world problems by attending Novus I-Corps Program at Rutgers – New Brunswick, a half-day introduction to I-Corps.

Propelus I-Corps hosted by Rutgers University

This four-session program helps researchers explore the customer perspective to inform how a discovery or innovation can become the basis of a successful startup or venture.

Apply by January 31

Propelus I-Corps hosted by NJIT

You will learn the I-Corps Methodology, which includes:

- Developing your Business Model – specifically Value Propositions and Customer Segments.

- Testing your business model hypotheses by talking to potential customers.

- Mapping the customer job workflow, ecosystem, and customer types.

Apply by February 3

Attention Undergraduate Student Innovators: Apply to ScarletPitch2025

ScarletPitch celebrates innovative ideas from undergraduate students across the Rutgers-New Brunswick campus. Whether it’s a social action project, a startup venture, or another big idea, ScarletPitch encourages creative problem-solving and developing presentation and communication skills. Winners receive cash prizes and the chance to compete in the state-wide competition.

View Flyer

Rutgers Office of Research

Virtual Institutional Review Board (IRB) Office Hours

DRAFT (Document Revision And Feedback Team)

Services hosts IRB Office Hours weekly.

Click here for more information on what to expect during Virtual IRB Office Hours.

Princeton Precision Health

2024 Seminar Series

Princeton Precision Health is a cross-cutting initiative that uses AI and data science to transform human health at all levels, from molecular to social to environmental, with the goal of enacting smart policy and evidence-based clinical practice.

Sleep Apnea and Sleep Stages on Apple Watch

Matt Bianchi

Health Technologies, Apple

Clinical Trials Office

Clinical Trial Agreements:

The Hows, Whats, and Whys

For Full-Time 2nd Year Doctoral Students

Are you a second-year doctoral student passionate about driving health equity? We strongly encourage applications from nonhealth-related disciplines who are seeking to use policy change to advance population health and health equity.

Learn more and apply today .

Apply by

March 11

Apply

CSL* Research Acceleration Initiative

CSL’s Research Acceleration Initiative aims to fast-track discovery of innovative biotherapies through partnerships between CSL and global research organizations.

Successful applicants will receive funding of up to $400,000 USD over 2 years.

Applications should align with a CSL Therapeutic Area: Cardiovascular and Renal, Hematology, Transplant and Immunology, Plasma Protein Research, Vaccines, and Genetic Medicine.

Applications close February 20

Rutgers researchers, contact Pragati Sharma at pragati.sharma@rutgers.edu to express interest in applying and to obtain instructions for the online application submission.

*CSL is a global biotechnology company.

Critical Path Institute

Translational Therapeutics Accelerator (TRxA)

TRxA is merging its efforts to support biologics and small molecule therapeutics under a single, unified Request for Proposal (RFP), aiming to provide the crucial resources needed to bridge the gap from lab discoveries to potential clinical applications.

Grants Manager

Department of Molecular Biology

Princeton University seeks a highly motivated, highly experienced individual to serve as Grants Manager (GM) in the Department of Molecular Biology. This position is fully remote.

Job Description

Apply Here

CTSA News and Events

NCATS, NIH, and Federal News and Events

Translational Science Education

and Training Challenge

Raise the profile of your education or training opportunity in translational science and help disseminate effective approaches nationally.

Phase 1 open until 04/30/25

Challenge types:

Scientific; Education and Training

Total cash prizes: $50,000

Science of Science Scholars

NIH is seeking new ways to engage the research community to help us understand the impacts of NIH policies and programs. If you’re a researcher working in the field of science of science, consider applying your expertise to accelerate scientific discoveries by becoming one of our inaugural Science of Science Scholars.

Registration is now open for the FDA-NIH Rare Disease Day — a two-day event co-hosted by NCATS and the U.S. Food and Drug Administration!

Collaboration Webinars from the

Trial Innovation Network

Hear from CTSA TIN experts on trial-related topics to improve your project

Exploring the Information Management Challenges of Clinical and Translational Research Teams, Betsy Rolland PhD, MLIS, MPH

February 19, 2025

12 - 1 pm

REDCap Randomization 2.0: A New Tool to Support Platform, Adaptive, and Decentralized Trials, Jonathan Casey MD, MSc

March 3, 2025

12 - 1 pm

NJ ACTS Publications

NJ ACTS Publication Highlights

Feasibility and Acceptability of an Online Family Literacy Program in an Under-Resourced Community During the COVID-19 Pandemic. Yewoon Choi, Nila Uthirasamy, David Córdoba, Lesley Mandel Morrow, Silvia Perez-Cortes, Usha Ramachandran, Shilpa Pai, Daniel Lima, Patricia A Shelton, Manuel E Jimenez. Journal of Developmental and Behavioral Pediatrics. 2023 Feb-Mar;44(2):e104-e110. doi: 10.1097/DBP.0000000000001155. Epub 2023 Jan 26.

Intercellular communication within the virus microenvironment affects the susceptibility of cells to secondary viral infections . Bokai Song, Xinlei Sheng, Joshua L Justice, Krystal K Lum, Peter J Metzger, Katelyn C Cook, James C Kostas, Ileana M Cristea. Science Advances. 2023 May 10;9(19):eadg3433. doi: 10.1126/sciadv.adg3433. Epub 2023 May 10.

Click Here for More NJ ACTS Publications

NJ ACTS is a partnership between Rutgers, NJIT, Princeton, and RWJ Barnabas Health. NJ ACTS advances clinical and translational science to develop new therapies and treatments and improve population health.

Components

Element B

Administration

Element C1

Workforce Development

Element C2

Community Engagement

Team Science

Element D1

*Biostatistics, Epidemiology &

Research Design (BERD)

*Regulatory Knowledge & Support

*Special Populations in Research

*FishFlow

*Genetically informed Research

Education & Training (GREAT)

Element D2

Pilots

Element D3

Informatics Services

Element E1

Clinical Translatable Science Research

Novel Genetic Services Model

Element E2

Clinical Translatable Science Research

Translating Evidence on Opioid Overdose

Additional Components

*Mentored Career Development K12

*Predoctoral Career Development T32

*Clinical Trials Office

Visit NJ ACTS

View NJ ACTS Calendar

CTSA Hub Funding Opportunities

Become a members of NJ ACTS.

How to cite the CTSA Grant

Connect with us

This newsletter is supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number, UM1TR004789 to Rutgers University. The content is solely the responsibility of the authors and does not represent the official views of the NIH.

New Jersey Alliance for Clinical and Translational Science

89 French St., Suite 4211

New Brunswick, NJ

Send story ideas to NJACTS@rbhs.rutgers.edu

UL1TR003017 (pre-5/1/2024), UM1TR004789 (starting 5/1/2024), KL2TR003018 and TL1TR003019 (pre-5/1/2024), K12TR004788-01A1 (starting 7/1/2024), T32TR004782-01 (starting 9/1/2024), R25TR004777-01A1 (starting 9/1/2024)

Visit our Website